Compounds > encainide
Page last updated: 2024-08-23

encainide and Kidney Diseases

encainide has been researched along with Kidney Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorne, JL; Renwick, AG; Slob, W; Walton, K1
Fronc, H; Hessen, SE; Kutalek, SP; Nydegger, CC; Porter, RS1
Roden, DM; Turgeon, J1
Gallo, DG; Quart, BD; Sami, MH; Wood, AJ1
Roden, DM; Wilkinson, GR; Wood, AJ; Woosley, RL1
Roden, DM; Woosley, RL1

Reviews

3 review(s) available for encainide and Kidney Diseases

ArticleYear
Encainide dosing in patients with severe renal dysfunction: report of a case and literature review.
    Clinical cardiology, 1992, Volume: 15, Issue:1

    Topics: Administration, Oral; Aged; Drug Administration Schedule; Electrocardiography; Encainide; Humans; Kidney Diseases; Male; Tachycardia

1992
Disposition kinetics of encainide and metabolites.
    The American journal of cardiology, 1986, Aug-29, Volume: 58, Issue:5

    Topics: Anilides; Arrhythmias, Cardiac; Biological Availability; Biotransformation; Encainide; Female; Humans; Kidney Diseases; Kinetics; Liver; Liver Cirrhosis; Pregnancy

1986
Clinical pharmacokinetics of encainide.
    Clinical pharmacokinetics, 1988, Volume: 14, Issue:3

    Topics: Anilides; Anti-Arrhythmia Agents; Biotransformation; Encainide; Half-Life; Health Status; Humans; Kidney Diseases; Liver Diseases

1988

Other Studies

3 other study(ies) available for encainide and Kidney Diseases

ArticleYear
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2002, Volume: 40, Issue:11

    Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride

2002
Pharmacokinetic profile of encainide.
    Clinical pharmacology and therapeutics, 1989, Volume: 45, Issue:6

    Topics: Anilides; Encainide; Humans; Kidney Diseases; Liver Diseases

1989
Drug interaction studies and encainide use in renal and hepatic impairment.
    The American journal of cardiology, 1986, Aug-29, Volume: 58, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anilides; Anti-Arrhythmia Agents; Anticoagulants; Antipsychotic Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cimetidine; Digoxin; Diuretics; Drug Interactions; Encainide; Humans; Hypoglycemic Agents; Kidney Diseases; Liver Diseases; Middle Aged; Prospective Studies; Protein Binding; Retrospective Studies

1986